Search
News
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.
News
Cerebral Cavernous Malformation Treatments Relieve Disparate Symptoms
Two patients with severe yet different neurological symptoms were referred to UCSF for emergent neurosurgical evaluation. Both were found to have previously undiagnosed cerebral cavernous malformations (CCMs), but each patient’s treatment was unique.
News
Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Immune checkpoint inhibitors have demonstrated limited efficacy in treating prostate cancer. Efforts to improve outcomes with combination therapies have mostly failed to demonstrate improvements compared to other types of cancer.
News
Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future Therapies
News
Treating Severe Depression with On-Demand Brain Stimulation
UCSF Health physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.
News
New Practice Guidance on Malnutrition, Frailty and Sarcopenia in Patients With Cirrhosis, Led by UCSF Researcher
The first-ever American Association for the Study of Liver Diseases (AASLD) Practice Guidance on the management of malnutrition, frailty and sarcopenia in patients with cirrhosis is now available.
News
UCSF Health Cancer Services Earns National Accreditation from the Commission on Cancer of the American College of Surgeons
The UCSF cancer program has been continuously accredited by the CoC since 1933, demonstrating its commitment to the best outcomes possible for its cancer patients.
News
UCSF Research Vital to First Drug for Deadly Bone Disease
The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation in place of soft and connective tissues.
News
UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UC San Francisco’s Heart and Vascular Center has been recognized by The American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry.
News
Deadly Dust: Engineered Stone Is Making California Workers Sick
Workers making artificial-stone slabs for the most popular type of countertops sold in the United States are developing a potentially deadly, irreversible lung disease from tiny particles of toxic dust, researchers from UC San Francisco and UCLA found...
News
New Complex Neurology Program Focuses on Hard-to-Diagnose Cases
In an effort to find answers to some of the most daunting neurological puzzles frustrating patients and clinicians alike, UC San Francisco has opened the Jan and Maria Manetti Shrem UCSF Neurology Complex Diagnosis Clinic, an innovative multidisciplinary center that tackles these issues head-on.
News
Telehealth Referral Leads to Diagnosis and Effective Treatment of Rare Neuropathy: Case Study
A 68-year-old man from Hawaii with acetylcholine receptor (AChR) antibody–positive myasthenia gravis and poorly controlled type 2 diabetes complicated by neuropathy had been receiving intravenous immunoglobulin (IVIg) and taking pyridostigmine for two years when ...
News
New Research Linking Type 1 Diabetes to Genetic Mutations May Lead to Precision Medicine
UCSF researchers have discovered specific genetic mutations that can cause type 1 diabetes. This groundbreaking work could result in effective precision treatments for patients.
News
Are New Therapies on the Horizon for Painful Skin Condition?
UCSF Health leads multi-center study of chronic inflammation of the skin that affects women and people of color disproportionately.
News
International Hematologic Conference Features UCSF Health Experts
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.
Document
Cerebrovascular Neurosurgery
As one of the highest volume and most experienced surgical programs in the nation for cerebrovascular disorders, we offer a wide range of treatment options tailored to each patient, leading to safer surgeries and better outcomes.
News
Advances in Treating Colorectal Cancer With Liver Metastases
Giving new hope to potentially thousands of patients, surgeons at UC San Francisco are now providing lifesaving procedures for many colorectal cancer patients whose cancer has spread to the liver.
News
UCSF Research Instrumental in Approval of Breakthrough Diabetes Therapy
The US Food and Drug Administration (FDA) recently approved the use of a new drug Teplizumab, an immunotherapy drug which has been shown to significantly delay the onset of type 1 diabetes.
Document
Cancer Immunotherapy Toxicity Evaluation (CITE) Program
UCSF Health’s new Cancer Immunotherapy Toxicity Evaluation (CITE) Program is a valuable resource for both patient care and provider consults.
News
Killing Pancreatic Cancer with T Cells that Turbocharge Themselves
Novel Immunotherapy Pumps Out Cancer-Killing Cytokines Only Inside the Tumor
News
John de Groot, MD, Named Division Chief of Neuro-Oncology at UCSF
John F. de Groot, MD, has been named the new chief of the Division of Neuro-Oncology within the Department of Neurological Surgery at UC San Francisco.
News
Gynecologic Cancer and Lynch Syndrome: Identifying Genetic Variants Leads to Precision Treatment
Given the increased risks associated with Lynch syndrome for gynecologic, colon and other cancers, physicians at the UCSF Gynecologic Oncology Center now approach testing, surveillance and treatment based on each patient’s individual genetic risk.
News
Artificial Intelligence and Wearable Sensors Put the Gait Lab in the Patient’s Pocket
UCSF orthopaedic surgeon Stefano Bini, MD, in collaboration with Google’s Advanced Technologies and Products (ATAP) division, is developing technology that will revolutionize how providers measure joint function and quantify joint disease. This groundbreaking approach uses cutting-edge machine-learning algorithms and data collected from inexpensive, wearable inertial sensors to accurately replicate gait lab outputs for a fraction of the cost of traditional methods, and in any context.
News
UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.
